CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » Cancer and Genetics

ConsultantLive.com.
 

Sex Ratio of Multiple Sclerosis

By Sreeram V. Ramagopalan, PhD | February 4, 2013
Dr Ramagopalan is Programme Leader at the University of Oxford, United Kingdom. He is the author or coauthor of over 100 peer-reviewed articles on multiple sclerosis.

An interesting feature that multiple sclerosis (MS) shares with many other immune-mediated diseases is that susceptibility is higher in females than males. However, the female to male ratio (sex ratio) of MS appears to have been changing over time.
 

A recent meta-analysis of epidemiological studies has shown that the worldwide sex ratio of MS has been substantially changing over the past century.1 This change is particularly clear in large population-based studies from Denmark and Canada.1,2  In Canada, the sex ratio of MS patients born in the 1930s was lower than 2: the ratio then increased to more than 3 females for each male patient in the latest birth cohort analyzed (1976-1980).
 

(MORE: Angioplasty Affords Symptom Relief for Patients With Multiple Sclerosis)

This intriguing epidemiological phenomenon warrants particular attention because the sex ratio of MS parallels MS incidence, and the increasing frequency of MS among females is a key driver of the increasing prevalence of this devastating disorder worldwide. A change that occurs within a century is too short a time for a genetic cause. This suggests that environmental factor/s are at work in a sex-specific manner.
 

What are the environmental agent/s that may be influencing the sex ratio of MS? An interesting hypothesis comes from a recent Australian study, which found that a higher number of offspring was inversely associated with the risk of a first clinical demyelinating event among women—but not men.3 However, other studies that have investigated how pregnancy modifies the risk of MS have reported conflicting results, Reproductive history may well have an influence on female susceptibility to MS, but this single factor is unlikely to entirely explain temporal trends in the MS sex ratio.

Vitamin D deficiency, Epstein-Barr virus (EBV) infection, and smoking history are known to influence MS risk and therefore represent additional plausible candidates.4 Unfortunately, sex-specific reliable longitudinal data on both vitamin D deficiency and EBV infection are lacking.

Interestingly, a recent study has shown how trends in sex ratio of smoking behavior in both Canada and Denmark strongly correlate with sex ratio changes of MS. However, this was mainly driven by a decline of smoking among men and cannot therefore fully explain the increased incidence of MS among females.

The sex ratio of MS currently remains an intricate puzzle with no clear solution as yet. Future research is urgently needed to understand the environmental factor/s involved to aid disease prevention strategies.5


References
1. Koch-Henriksen N, Sorensen PS. The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol. 2010;9:520-532.
2. Orton SM, Herrera BM, Yee IM, et al. Sex ratio of multiple sclerosis in Canada: a longitudinal study. Lancet Neurol. 2006;5:932-936.
3. Ponsonby AL, Lucas RM, van der Mei IA, et al. Offspring number, pregnancy, and risk of a first clinical demyelinating event: the AusImmune Study. Neurology. 2012;78:867-874.
4. Ramagopalan S, Dobson R, Meier UC, Giovannoni G. Multiple sclerosis: risk factors, prodromes, and potential causal pathways. Lancet Neurol. 2010;9:727-739.
5. Palacios N, Alonso A, Bronnum-Hansen H, Ascherio A. Smoking and increased risk of multiple sclerosis: parallel trends in the sex ratio reinforce the evidence. Ann Epidemiol. 2011;21:536-542.
 

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.

MS primary care

Multiple Sclerosis: Role of Physical Therapy in Disease-Related Mobility Deficits

Simplified Testing for Cognitive Function in Multiple Sclerosis

Guidance for Treating Pediatric Multiple Sclerosis With Grown-Up Medications

Multiple Sclerosis: What Triggers Exacerbations?

Multiple Sclerosis: 10 Things Primary Care Providers Need to Know Now

The Importance of Bone Health in Multiple Sclerosis

Disease Modifying Therapies: Do They Modify Short- and Long-Term in Multiple Sclerosis?

Pregnancy, Breast Feeding—and Risk of Relapse in Multiple Sclerosis

Multiple Sclerosis and Epstein-Barr Virus: Is there a Connection?

The Genetics of Multiple Sclerosis: 4 Key Points

Venous Thromboembolism and Multiple Sclerosis

In Multiple Sclerosis, Motivational Interviewing Can Improve Exercise Experience

Smoking and Multiple Sclerosis

Complementary Therapies in Multiple Sclerosis: Why Mind-Set Is Everything

Wellness Program Improves Self-Efficacy in Multiple Sclerosis

Multiple Sclerosis and the Primary Care Physician’s Key Role

Intrathecal Methotrexate: A Treatment Option for Patients with Progressive Multiple Sclerosis?

Angioplasty Affords Symptom Relief for Patients With Multiple Sclerosis

Sex Ratio of Multiple Sclerosis





CancerNetwork on Facebook


 
RELATED CONTENT

New Therapeutic Target, MDM4, Found in Cutaneous Melanoma
July 24, 2012
Study Finds Different Treatment Responses Between BRCA2- and BRCA1-Mutated Ovarian Cancers
ONCOLOGY,  October 11, 2011
Screening Identifies Mechanisms of Drug Resistance to PI3K Inhibitors
ONCOLOGY,  September 27, 2011
Novel DNA-Silencing Function of BRCA1 Discovered
ONCOLOGY,  September 7, 2011
Role for PTEN in DNA Damage Removal and Prevention of Non-Melanoma Skin Cancer
July 28, 2011
 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
   SEARCH MEDICA RX
   Browse drugs by name:
A B C D E F G H I J
K L M N O P Q R S T
U V W X Y Z All      
   Search for drugs:
Search

 

 
FROM PHYSICIANS PRACTICE
Primary Care Can't Thrive Without Nurse Practitioners
Courtney H. Lyder, ND,  May 17, 2013
With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.
VWhat Physicians Can Learn from the Allscripts EHR Lawsuit
Marisa Torrieri,  May 16, 2013
Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse?
Eight Ways ICD-9 Will Still Matter to Medical Practices
Brenda Edwards, CPC,  May 15, 2013
What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it.
Seven Ways Technology Can Speed Up Patient Collections
Cheyenne Brinson,  May 15, 2013
Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right.
Four Reasons Private Medical Practice is Becoming Extinct
Carol Stryker,  May 15, 2013
It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Colorectal Lesions
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • “This Is My Last Day on Earth”
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • The ABCDEs of Moles and Melanomas
  • “This Is My Last Day on Earth”
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Colorectal Lesions
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • Bone Metastases
  • Palliative Radiotherapy in Elderly Patients With Bone Metastases Improves Quality of Life
  • Staying Fit Could Ward Off Lung and Colorectal Cancer for Middle-Age Men
  • Obesity Impairs Efficacy of L-Asparaginase in Leukemia Treatment
  • New AUA Guidelines for Prostate Cancer Screening
Click here to subscribe to our newsletter
 
COMMENTS
  • Most Commented
  • Most Recent
  • “This Is My Last Day on Earth”
  • Financial Toxicity, Part II: How Can We Help With the Burden of Treatment-Related Costs?
  • Patient Quality of Life Endpoints in Oncology Trials, Part II
  • Who's Coding Whom?
  • “How Do I Say This Nicely? Your Oncologist Wasn't Following Guidelines”
  • Preventing Exposure to Hazardous Drugs
  • Cancer Metabolism as a Therapeutic Target
  • Study: Cholesterol Drugs Reduced Risk of Prostate Cancer Death
  • “This Is My Last Day on Earth”
  • ONS: Safe Handling of Chemotherapy
Click here to subscribe to our newsletter


 
SearchMedica Search Result

Find peer-reviewed literature and websites for practicing medical professionals

CME on Cancer And Genetics
Evidence on Cancer And Genetics
Guidelines on Cancer And Genetics
Patient Education on Cancer And Genetics
Clinical Trials on Cancer And Genetics
Practical Articles on Cancer And Genetics
Research and Reviews on Cancer And Genetics
All "Cancer And Genetics" results


CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy